SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
AmorChem l.p. Invests in a Novel Cholesterol-Lowering Biologic Product Targeting PCSK9 and Puts in Place a Master Agreement With Univalor, L.P.